<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="50219">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01793129</url>
  </required_header>
  <id_info>
    <org_study_id>NICHD-NRN-0051</org_study_id>
    <secondary_id>U10HD021364</secondary_id>
    <secondary_id>U10HD040689</secondary_id>
    <secondary_id>U10HD021385</secondary_id>
    <secondary_id>U10HD027851</secondary_id>
    <secondary_id>U10HD027853</secondary_id>
    <secondary_id>U10HD027856</secondary_id>
    <secondary_id>U10HD027904</secondary_id>
    <secondary_id>U10HD027880</secondary_id>
    <secondary_id>U10HD034216</secondary_id>
    <secondary_id>U10HD021373</secondary_id>
    <secondary_id>U10HD040492</secondary_id>
    <secondary_id>U10HD053109</secondary_id>
    <secondary_id>U10HD040461</secondary_id>
    <secondary_id>U10HD068244</secondary_id>
    <secondary_id>U10HD068263</secondary_id>
    <secondary_id>U10HD068270</secondary_id>
    <secondary_id>U10HD068278</secondary_id>
    <secondary_id>U10HD068284</secondary_id>
    <secondary_id>U10HD036790</secondary_id>
    <nct_id>NCT01793129</nct_id>
  </id_info>
  <brief_title>Preemie Hypothermia for Neonatal Encephalopathy</brief_title>
  <official_title>A Randomized Trial of Targeted Temperature Management With Whole Body Hypothermia For Moderate And Severe Hypoxic-Ischemic Encephalopathy In Premature Infants 33-35 Weeks Gestational Age.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Center for Research Resources (NCRR)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</source>
  <oversight_info>
    <authority>United States: Federal Government</authority>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a randomized, controlled trial to assess safety and effectiveness of whole
      body hypothermia for 72 hours in preterm infants 33-35 weeks gestational age (GA) who
      present at &lt;6 hours postnatal age with moderate to severe neonatal encephalopathy (NE).  The
      study will enroll infants with signs of NE at 18 NICHD Neonatal Research Network sites, and
      randomly assign them to either receive hypothermia or participate in a non-cooled control
      group.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Most clinical studies of neonatal encephalopathy (NE) and potential interventions have
      focused on infants ≥36 weeks GA. Although many interventions have been suggested and
      assessed for prevention or palliation of NE, the only one currently supported by rigorous
      clinical evidence to improve outcome in human newborns has been hypothermia implemented at
      &lt;6 hours of postnatal age and maintained for 72 hrs.  Data about diagnosis, frequency,
      severity, and outcome of NE in infants 33-35 weeks GA are sparse.

      This trial will assess safety and effectiveness of whole body hypothermia for 72 hours in
      preterm infants 33-35 weeks gestational age (GA) who present at &lt;6 hrs postnatal age with
      moderate to severe neonatal encephalopathy. Infants 33 0/7 to 35 6/7 weeks GA (best
      obstetrical estimate) and greater than or equal to 1500 grams birth weight (selected to
      minimize potential difficulties placing esophageal probe) who meet clinical, biochemical and
      neurologic criteria for moderate to severe NE will be randomized to either whole body
      hypothermia or participate in a non-cooled control group. The primary outcome will be death
      or moderate to severe disability at 18-22 months corrected age. The presence or absence of
      disability will be determined by the standard NRN interdisciplinary follow-up exam.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">October 2018</completion_date>
  <primary_completion_date type="Anticipated">August 2016</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Death or moderate or severe disability</measure>
    <time_frame>Birth to 18-22 months corrected age</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of deaths in the NICU and following discharge</measure>
    <time_frame>Birth to 18-22 months corrected age</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Differences in MRI findings after cessation of cooling/control obtained</measure>
    <time_frame>Birth to 40 weeks corrected age</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of infants with moderate and severe disability</measure>
    <time_frame>Birth to 18-22 months corrrected age</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Causes of Death</measure>
    <time_frame>Birth to 18-22 months corrrected age</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>withdrawal of support and reasons for such will be tracked; attempts will be made to obtain autopsy whenever possible</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurological injury by cranial ultrasound within 24 hours of enrollment</measure>
    <time_frame>Birth to 2 days of life</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">168</enrollment>
  <condition>Infant, Newborn</condition>
  <condition>Hypoxia, Brain</condition>
  <condition>Hypoxia-Ischemia, Brain</condition>
  <condition>Encephalopathy, Hypoxic-Ischemic</condition>
  <condition>Hypoxic-Ischemic Encephalopathy</condition>
  <condition>Ischemic-Hypoxic Encephalopathy</condition>
  <arm_group>
    <arm_group_label>Whole-body Hypothermia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Induced Whole-body hypothermia (with a target esophageal temperature of 33.5°C) for 72 hours</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normothermia</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Control group (with esophageal temperature at or near 37.0°C) for 72 hours</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hypothermia</intervention_name>
    <description>Induced Whole-body hypothermia (with a target esophageal temperature of 33.5°C) for 72 hours</description>
    <arm_group_label>Whole-body Hypothermia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Normothermic Control</intervention_name>
    <description>Normothermic Control group (with esophageal temperature at or near 37.0°C) for 96 hours</description>
    <arm_group_label>Normothermia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Infants 33 0/7 to 35 6/7 weeks GA (best obstetrical estimate)

          -  Infants weight greater than or equal to 1500 grams at birth

          -  Postnatal age less than 6 hours

          -  Infants who meet clinical, biochemical and neurologic criteria for moderate to severe
             NE:

        Biochemical:  Cord gas or blood gas within first hour of life with pH ≤7.00 or base
        deficit  (BD) ≥16 mEq/L OR

        Acute perinatal event (e.g., abruptio placenta, cord prolapse, uterine rupture, severe FHR
        abnormality such as variable or late decelerations) AND Requirement for positive pressure
        ventilation for apnea or poor respiratory effort since birth for at least 10 minutes OR 10
        minute Apgar score ≤5

        AND

        Neurologic:

        Seizures OR modified Sarnat score with abnormalities in at least 3 of the 6 categories; at
        least one must be altered level of consciousness (lethargy or stupor/coma) as determined
        by a certified examiner (All infants who meet criteria for potential inclusion will
        undergo standard neurologic exam as for infants ≥36 wks GA being considered for
        hypothermia, with findings recorded)

        Exclusion Criteria:

          -  Receipt of sedative, analgesic or paralytic agent that may confound the qualifying
             neurologic exam

          -  Etiology of NE not likely to be hypoxic-ischemic in origin

          -  Major congenital anomaly that may confound outcome

          -  Considered to be moribund and will not be receiving full intensive care

          -  Equipment and/or appropriate staff not available

          -  Core temperature &lt; 33.5oC for more than one hour at time of screening

          -  Unable to randomize by 6 hours of age

          -  Infant needs ECMO

          -  All blood gases (cord and postnatal at &lt; 1hr of age) have a pH &gt; 7.15 AND a base
             deficit &lt; 10mEq/L
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>33 Weeks</minimum_age>
    <maximum_age>35 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michele C Walsh, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Case Western Reserve University, Rainbow Babies and Children's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Seetha Shankaran, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wayne State University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Abbot R Laptook, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brown University, Women &amp; Infants Hospital of Rhode Island</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ron N Goldbert, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Barbara J Stoll, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Emory University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Brenda B Poindexter, MD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indiana University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Abhik Das, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>RTI International</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Krisa P Van Meurs, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kurt Schibler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cincinnati Children's Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wally A Carlo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Edward F Bell, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Iowa</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kristi L Watterberg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of New Mexico</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pablo J Sanchez, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Texas Southwestern Medical Center at Dalla</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kathleen A Kennedy, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Texas Health Science Center, Houston</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Barbara Schmidt, MD, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Carl T D'Angio, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Rochester</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Uday Devaskar, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Los Angeles</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Leif Nelin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Research Institute at Nationwide Children's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>William Truog, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Mercy Hospital-Kansas City, MO</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Roger G Faix, MD</last_name>
    <phone>801-581-7052</phone>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rosemary D Higgins, MD</last_name>
    <phone>301-435-5575</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35233</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Waldemar A. Carlo, MD</last_name>
      <phone>205-934-4680</phone>
    </contact>
    <investigator>
      <last_name>Waldemar A. Carlo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California - Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90025</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Uday Devaskar, MD</last_name>
      <phone>310-825-9314</phone>
    </contact>
    <investigator>
      <last_name>Uday Devaskar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Krisa P. Van Meurs, MD</last_name>
      <phone>650-723-5711</phone>
    </contact>
    <investigator>
      <last_name>Krisa P. Van Meurs, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30303</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Barbara J. Stoll, MD</last_name>
      <phone>404-727-2456</phone>
    </contact>
    <investigator>
      <last_name>Barbara J. Stoll, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Indiana University</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Brenda B. Poindexter, MD MS</last_name>
      <phone>317-274-4768</phone>
    </contact>
    <investigator>
      <last_name>Brenda B. Poindexter, MD MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Iowa</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Edward F. Bell, MD</last_name>
      <phone>319-356-4006</phone>
    </contact>
    <investigator>
      <last_name>Edward F. Bell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wayne State University</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Seetha Shankaran, MD</last_name>
      <phone>313-745-1436</phone>
    </contact>
    <investigator>
      <last_name>Seetha Shankaran, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Mercy Hospital</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>William Truog, MD</last_name>
      <phone>816-234-3592</phone>
    </contact>
    <investigator>
      <last_name>William Truog, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of New Mexico</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87131</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kristi L. Watterberg, MD</last_name>
      <phone>505-272-8609</phone>
    </contact>
    <investigator>
      <last_name>Kristi L. Watterberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Rochester</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Carl T D'Angio, MD</last_name>
      <phone>585-273-4911</phone>
    </contact>
    <investigator>
      <last_name>Carl T D'Angio, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Duke University</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ronald N. Goldberg, MD</last_name>
      <phone>919-681-6024</phone>
    </contact>
    <investigator>
      <last_name>Ronald N. Goldberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>C. Michael Cotten, MD MHS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>RTI International</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Abhik Das, PhD</last_name>
      <phone>301-230-4640</phone>
    </contact>
    <investigator>
      <last_name>Abhik Das, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cincinnati Children's Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45267</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kurt Schibler, MD</last_name>
      <phone>513-636-3972</phone>
    </contact>
    <investigator>
      <last_name>Kurt Schibler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Case Western Reserve University, Rainbow Babies and Children's Hospital</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michele C. Walsh, MD, MS</last_name>
      <phone>216-844-3387</phone>
    </contact>
    <contact_backup>
      <last_name>S.</last_name>
    </contact_backup>
    <investigator>
      <last_name>Michele C. Walsh, MD MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Research Institute at Nationwide Children's Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Leif Nelin, MD</last_name>
      <phone>614-355-6724</phone>
    </contact>
    <investigator>
      <last_name>Leif Nelin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Univeristy of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Barbara Schmidt, MD</last_name>
      <phone>215-662-3228</phone>
    </contact>
    <investigator>
      <last_name>Barbara Schmidt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Brown University, Women &amp; Infants Hospital of Rhode Island</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Abbot R. Laptook, MD</last_name>
      <phone>401-274-1122</phone>
      <phone_ext>43200</phone_ext>
    </contact>
    <investigator>
      <last_name>Abbot R. Laptook, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern Medical Center at Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75235</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Myra Myckoff, MD</last_name>
      <phone>214-648-3923</phone>
    </contact>
    <investigator>
      <last_name>Myra Wyckoff, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas Health Science Center at Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kathleen A. Kennedy, MD MPH</last_name>
      <phone>713-500-6708</phone>
    </contact>
    <investigator>
      <last_name>Kathleen A. Kennedy, MD MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jon E. Tyson, MD MPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://neonatal.rti.org</url>
    <description>Neonatal Research Network website</description>
  </link>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 26, 2013</lastchanged_date>
  <firstreceived_date>February 13, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>NICHD Neonatal Research Network</keyword>
  <keyword>Hypoxic-ischemic encephalopathy (HIE)</keyword>
  <keyword>Hypothermia</keyword>
  <keyword>Neonatal depression</keyword>
  <keyword>Perinatal asphyxia</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypoxia, Brain</mesh_term>
    <mesh_term>Hypoxia-Ischemia, Brain</mesh_term>
    <mesh_term>Brain Ischemia</mesh_term>
    <mesh_term>Hypothermia</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Brain Damage, Chronic</mesh_term>
    <mesh_term>Delirium</mesh_term>
    <mesh_term>Encephalitis</mesh_term>
    <mesh_term>Hepatic Encephalopathy</mesh_term>
    <mesh_term>Neurotoxicity Syndromes</mesh_term>
    <mesh_term>Anoxia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
